SCHEMBL28327170

SCHEMBL28327170

CN1CC(C(=O)O)C1c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ POLB P06746 2/20 0.47
▸ LMNA P02545 1/20 0.44
▸ HTT P42858 1/20 0.43
▸ ACE P12821 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.41
▸ SLC6A2 P23975 2/20 0.41
▸ SLC6A4 P31645 2/20 0.41
▸ SLC6A3 Q01959 2/20 0.41
▸ AKR1C3 P42330 1/20 0.41
▸ AKR1C1 Q04828 1/20 0.41
▸ TLR2 O60603 2/20 0.40
▸ TLR1 Q15399 2/20 0.40
▸ BRD4 O60885 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28760965 0.81 CYP2D6 (0.43) SLC6A2SLC6A4SLC6A3
SCHEMBL9294538 0.80 CHRNB2 (0.53) MEN1KMT2APOLBLMNAHTT
SCHEMBL9294533 0.80 CHRNB2 (0.53) MEN1KMT2APOLBLMNAHTT
SCHEMBL9294528 0.80 CHRNB2 (0.53) MEN1KMT2APOLBLMNAHTT
SCHEMBL10685501 0.74 LMNA (0.58) MEN1KMT2APOLBLMNAHTT
SCHEMBL23117711 0.73 KDM1A (0.42) MEN1KMT2APOLB
SCHEMBL13525555 0.73 MEN1 (0.64) MEN1KMT2AALDH1A1SLC6A2SLC6A4
SCHEMBL13525552 0.73 MEN1 (0.64) MEN1KMT2AALDH1A1SLC6A2SLC6A4
SCHEMBL26134488 0.72 SLC6A2 (0.44) ALDH1A1SLC6A2SLC6A4SLC6A3
SCHEMBL22492017 0.71 KMT2A (0.67) MEN1KMT2APOLBLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110177783-A Hormone receptor modulators for the treatment of metabolic conditions and disorders 阿德利克斯股份有限公司 2019-08-27 — — CN claimed
CN-110177783-A Hormone receptor modulators for the treatment of metabolic conditions and disorders 阿德利克斯股份有限公司 2019-08-27 — — CN disclosed
Send feedback